| Literature DB >> 31819342 |
Mariona Esquerdo-Barragán1,2, Matthew J Brooks3, Vasileios Toulis1,2,4, Anand Swaroop3, Gemma Marfany1,2,4.
Abstract
Purpose: Genes involved in the development and differentiation of the mammalian retina are also associated with inherited retinal dystrophies (IRDs) and age-related macular degeneration. Transcriptional regulation of retinal cell differentiation has been addressed by genetic and transcriptomic studies. Much less is known about the posttranslational regulation of key regulatory proteins, although mutations in some genes involved in ubiquitination and proteostasis-E3 ligases and deubiquitinating enzymes (DUBs)-cause IRDs. This study intends to provide new data on DUB gene expression during different developmental stages of mouse and human fetal retinas.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31819342 PMCID: PMC6887694
Source DB: PubMed Journal: Mol Vis ISSN: 1090-0535 Impact factor: 2.367
Figure 1Diagram of murine photoreceptor development with key regulatory transcription factors. From embryonic stems cells, several transcription factors at specific developmental times are required to determine retinal precursor cells and eventually, give rise to fully mature photoreceptors. PAX6, OTX2, RORβ, CRX, NRL, NR2E3, and TRβ2 are considered the key regulators of retinal development and photoreceptor differentiation. Blue bullets indicate posttranslational modification of NRL and NR2E3 by SUMO that regulates cone versus rod fate in photoreceptor precursor cells.
List of human and mouse DUBs used in transcriptomics analysis classified by families and alphabetical name.
| USP1 | USP3 | USP4 | USP5 | COPS5 (CSN5) | COPS6 | EIF3H | MPND |
| USP6a | USP7 | USP8 | USP9 | MYSM1 | PRPF8 | PSMD7 | PSMD14 (POH1) |
| USP10 | USP11 | USP12 | USP13 | STAMBP (AMSH) | STAMBPL1 (AMSH-LIKE) | | |
| USP14 | UPS15 | USP16 | USP17L2b | | |||
| USP17LEb | USP18 | USP20 | USP21 | ||||
| USP22 | USP24 | USP25 | USP26 | ATXN3 | JOSD1 | JOSD2 | TAF1D (JOSD3) |
| USP27X | USP28 | USP29 | USP30 | | |||
| USP31 | USP32 | USP33 | USP34 | ||||
| USP35 | USP36 | USP37 | USP38 | OTUB1 | OTUB2 | OTUD1 | OTUD3 |
| USP39 | USP40 | USP41c | USP42 | OTUD4 | OTUD5 | OTUD6A | OTUD6B |
| USP43 | USP44 | USP45 | USP46 | OTUD7A | OTUD7B | PARPF11 | TNFAIP3 |
| USP47 | USP48 | USP49 | USP50 | VCPIP1 | ZRANB1 | | |
| USP51 | USP53 | USP54 | USPL1 | | |||
| CYLD | PAN2 (USP52) | TBC1D1 | | ||||
| | BAP1 | UCHL1 | UCHL3 | UCHL5 | |||
a Gene identified only in the human genomes b Family of retrogenes derived from the USP17 gene c Gene identified only in the human genomes, paralogue of USP18
Figure 2Expression heatmap of deubiquitinating enzyme genes in several human and mouse developmental stages. WT, wild-type mouse retinas; CRX, mouse Crx knockout (KO) retinas; NRL, mouse Nrl knockout retinas. For the mouse WT retinas, the data shown correspond to the embryonic 11 (E11), E12, E14, E16, postnatal day 0 (P0), P2, P4, P6, P10, P14, and P21 stages. Rod- and cone-like data correspond to RNA-sequencing (RNA-seq) from flow-sorted rods and cone-like cells from stages P0, P2, P4, P10, P14, and P21. For the human retina, the data shown correspond to day 52 postfertilization (D52), D53, D57 (two different samples: D57.1 and D57.2), D67 (two different samples: D67.1 and D67.2), D70, D80, D87, D94 (two different samples: D94.1 and D94.2), D105, D107, D115, D125, D132, and D136 (details of the RNA-seq libraries and references are in the text). The color key (upper left corner) indicates the relative expression values. Blue indicates low expression; red, high expression; intermediate expression is colored in white and light colors (as described in [10,31]).
Data summary of the 12 pre-selected genes as plausible candidates to contribute to retinal development.
| | | | | | |
|---|---|---|---|---|---|
| | Decrease during development in whole retina and in rods, but not in cones. | CRX | Adrenal Gland, Cerebellum, Spleen, Thymus | 3 dpf: eyes shape, abnormal retinotectal projection (ZF) | Involved in endocytosis. Almost no bibliography |
| | Low expression throughout development, small increase from P10. Continuous expression in rods. | — | Testis | — | Involved in NFκB signaling. Role as oncogene: via deubiquitination of EGFR |
| | Highly expressed in the retina. Shut down in rods at P21, but maintenance in cones. | CRX | Cerebellum, CNS, Testis, Cortical Plate, Frontal Cortex, Limb, Liver, Placenta, Testis, Urinary Bladder | — | mRNA Deadenylation. |
| | Decrease in rods from P10, but not in cones. | CRX, NRL | Cerebellum, CNS, Cortical Plate, Female Gonad, Frontal Cortex, Limb | CNS necrosis (ZF) | DNA damage. Tumour-associated marker in grastrocarcinoma, and Adrenal tumors, Regulation of NFκB signaling via p53. |
| | Strong shut down in rods and not in cones | — | Cerebellum, CNS, Cortical Plate, Frontal Cortex, Gonadal Fat Pad, Kidney, Large Intestine, Placenta, Testis | — | Transport to the Golgi, Protein folding; NFκB signaling; DNA repair after double-strand DNA breaks. Possibly related to X-linked retinal disorders. |
| | Stable expression in retina, with a slight shut down only in rods. | — | Cerebellum, CNS, Cortical Plate, Frontal Cortex, Liver, Placenta, Testis, | Neuronal phenotype slower adults, early death (D).
Reduced USP14 levels cause tremors, abnormal brain morphology, altered synaptic transmission and increased apoptosis (H) | Involved in Parkinson. Role as oncogene in breast, hepatolcellular carcinoma, lung adenocarcinoma. Decreases apoptosis. |
| | Stable expression in retina, with a slight shut down only in rods | NRL | Adrenal Gland, Cerebellum, CNS, Colon, Cortical Plate, Heart, Kidney, Large Intestine, Limb, Testis | 2dpf: small eyes, and at 4dpf: deformed eyes (ZF). | Interferon signaling. Involved in mitophagy. Role as oncogene via TGFβ. |
| | Very low levels of expression in retina, with a slight shut down in rods from P10. | — | Kidney, Thymus | Earlier adult death (D).
3dpf: small eyes (ZF). | NFκB signaling. β2 adrenergic receptor recycling. Tyroid hormone activation. |
| | Highly expressed throughout development with a shut down in rods from P10. | CRX | Testis | (Neuronal) slower adults, early death (D).
−/− Homozygotes are embryonic lethal (M) | Role as oncogene in liver, colon, lung, gastric, nasopharyngeal, pancreas (via histone and p53 regulation). |
| | Slight shut down both in retina and rods from P10, but not in cones. | CRX | CNS, Limb, Testis | Larval death (D).
2dpf: small eyes (ZF) | Role in cancer, promotes cell proliferation. |
| | Low expression in rods with a final strong shut down. Moderate-high expression in postnatal cones. | — | Adrenal Gland, Duodenum, Adipocytes, Thymus, Kidney, Spleen, Female Gonad, Mammal Gland, Colon | — | Role in neurotransmission circuitry, involved in behavior. |
| | Strong difference between rods (low) and cones (high) expression. | CRX | Cerebellum, CNS; Placenta | 3dpf: small eyes (ZF) | DNA repair in Fanconi Anemia |
aRNA-seq on total retina lists the expression features observed in the RNA-seq data. bChIP-Seq “CRX” and “NRL” indicate that the gene promoter was bound by CRX or NRL, respectively, in ChIP assays. cRNA-seq on tissues list tissues in which the DUB gene is mainly expressed. dPhenotype includes the phenotypic traits reported in different model organisms caused by mutations in these genes [3,30,34]. e [35]. f [36]. (D): Drosophila (H): Human; (M): Mouse; (ZF): Zebrafish.
Figure 3Diagram showing the criteria considered for the selection of five relevant DUB genes in the retina. For each of the selected genes, Josd1, Otud7b, Usp22, Usp46, and Usp48, the composite images show the following. A: Transcriptome analysis of each selected gene, extracted from Figure 2. B: Track view of CRX- and NRL-chromatin immunoprecipitation sequencing (ChIP-seq) density profiles (after CRX and NRL immunoprecipitation, respectively) using postnatal day 28 (P28) wild-ty[e (WT) mouse retinas, visualized using the UCSC genome browser (https://neicommons.nei.nih.gov/). C: Pattern of expression with in situ hybridization in WT mouse retinas (reported in [30]). PhR, photoreceptor cell layer; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. D: Described phenotypes in either knockout or knockdown animal models (references in Table 2).